AbbVie Strikes $2.54 Billion Deal with Germany’s Disco Pharmaceuticals for Cancer Therapies
US pharmaceutical giant AbbVie has agreed to invest up to $2.54 billion in a partnership with Germany-based biotechnology company Disco Pharmaceuticals to develop next-generation cancer treatments. The deal focuses on developing bispecific antibody therapies...
Krishnakumar P.: Carrying NUPAL’s 500-Year Ayurvedic Legacy to the World
Before the first drop of steam rose from a modern factory, the air of Kerala was already heavy with the fragrance of boiling herbal oils, crushed roots, and damp earth. Centuries ago, deep within...
FDA Approves Wearable Version of Sanofi’s Blood Cancer Drug Sarclisa
The U.S. Food and Drug Administration (FDA) has approved a wearable version of Sanofi’s blood cancer drug Sarclisa, marking the first FDA-approved cancer treatment that can be administered through an on-body injector attached to...





